Contact
Spanish

Midatech is a nanomedicine company focused on the development and commercialisation of multiple, high-value, targeted therapies for major diseases with unmet medical need.

Midatech is advancing a pipeline of novel clinical and pre-clinical product candidates based on its proprietary drug conjugate and sustained release delivery platforms with a clear focus on the key therapeutic areas of diabetes, cancer and neuroscience/ophthalmology. Midatech’s strategy is to develop its products in-house in rare cancers and with partners in other indications, and to accelerate growth of its business through strategic acquisition of complementary products and technologies.

Latest News...
Aug 13, 2015
- Development of sustained delivery formulations for rapidly growing ophthalmology market - Underpins... Read More
Jul 20, 2015
Midatech (AIM: MTPH) , the international specialty pharmaceutical company with a diversified portfolio of... Read More
Apr 14, 2015
Midatech Pharma (AIM: MTPH) , the international specialty pharmaceutical with a diversified portfolio of... Read More
Home

Careers

T&Cs

Privacy and cookie policy

Sitemap

  © Copyright 2014 Midatech